Pharmaceutical companies are heading toward a steep patent cliff that could strip more than $230 billion in US drug sales ...

Keytruda (pembrolizumab) is approved for head and neck squamous cell carcinoma as a perioperative treatment regimen.

Take Keytruda, a leading cancer drug. It’s almost entirely manufactured in Ireland. If new tariffs make it unaffordable, there is no U.S.-made alternative patients can turn to.

The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile countries for genetic engineering and subsequent infusion” back ...

The shipments have vaulted Ireland, a country of only five million people, into the second-largest goods-trade imbalance with the U.S., trailing only China.

Merck has obtained the Food and Drug Administration’s permission for Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, for the treatment of adult patients with resectable locally advanced ...

Session ID: 2025-07-05:10a1c60e64bc8d9a3e64a294 Player Element ID: Vf442f6fa_a10e_431e_bef8_08df4b04895f_6374239823112 ...

Daniel White battles lung cancer with Keytruda.His doctor, Melissa Crawley from Texas Oncology added, "Daniel's doing really well. We've now had another CT scan that shows some continued evidence ...

The FDA granted Merck’s application priority review on February 25, 2025, with approval following on June 13, 2025, based on interim results from Keytruda’s Phase 3 KEYNOTE-689 trial.

VIENNA, Va., June 18, 2025--FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine.

Iran and Israel accused each other of endangering commercial activity in sea lanes around the Gulf and the Red Sea at the UN's shipping agency on Wednesday, as their military conflict escalated.